Format

Send to

Choose Destination
Behav Pharmacol. 2018 Aug;29(5):469-472. doi: 10.1097/FBP.0000000000000382.

Medication overuse headache following repeated morphine, but not [INCREMENT]9-tetrahydrocannabinol administration in the female rat.

Author information

1
Department of Integrative Physiology and Neuroscience, Graduate Program in Neuroscience.
2
Department of Psychology, Washington State University Vancouver, Vancouver, Washington, USA.
3
Translational Addiction Research Center, Washington State University, Pullman.

Abstract

The potential of [INCREMENT]-tetrahydrocannabinol (THC) as a treatment for migraine depends on antinociceptive efficacy with repeated administration. Although morphine has good antinociceptive efficacy, repeated administration causes medication overuse headache (MOH) - a condition in which the intensity/frequency of migraine increases. The present study compared the effect of repeated morphine or THC administration on the magnitude and duration of migraine-like pain induced by a microinjection of allyl isothiocyanate (AITC) onto the dura mater of female rats. Acute administration of THC or morphine prevented AITC-induced depression of wheel running. This antinociception was maintained in rats treated repeatedly with THC, but not following repeated administration of morphine. Moreover, repeated morphine, but not THC administration, extended the duration of AITC-induced depression of wheel running. These data indicate that tolerance and MOH develop rapidly to morphine administration. The lack of tolerance and MOH to THC indicates that THC may be an especially effective long-term treatment against migraine.

PMID:
29462111
PMCID:
PMC6035110
DOI:
10.1097/FBP.0000000000000382
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center